Grifols reported EUR679.73M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Alaunos Therapeutics USD 2.21M 2.2M Sep/2025
aTyr Pharma USD 97.99M 97.9M Sep/2025
GlaxoSmithKline GBP 4.03B 119.13M Sep/2025
Grifols EUR 679.73M 0 Sep/2025